Taiwan
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 19.77 M
|
Dec. 31, 2023 | USD 1.81 | NA |
|
Taiwan |
|
2 |
USD 12.59 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Taiwan |
|
3 |
USD 626.46 K
|
Dec. 31, 2023 | USD 2.60 | NA |
|
Taiwan |
|
4 |
USD 32.96 K
|
Dec. 31, 2023 | USD 1.58 | NA |
|
Taiwan |
|
5 |
USD -651.02 K
|
Dec. 31, 2023 | USD 0.34 | NA |
|
Taiwan |
|
6 |
USD -1.20 M
|
Dec. 31, 2023 | USD 0.61 | NA |
|
Taiwan |
|
7 |
USD -1.81 M
|
Dec. 31, 2023 | USD 0.95 | NA |
|
Taiwan |
|
8 |
USD -5.31 M
|
Dec. 31, 2023 | USD 0.97 | NA |
|
Taiwan |
The Vaccines company in Taiwan with the highest Net Cash Used Provided By Financing Activities is OBI Pharma, Inc. (Taipei Exchange: 4174.TWO) at USD 19.77 M.
The Vaccines company in Taiwan with the lowest Net Cash Used Provided By Financing Activities is Microbio Co., Ltd. (Taipei Exchange: 4128.TWO) at USD -5.31 M.
The top 10 Vaccines companies in Taiwan by Net Cash Used Provided By Financing Activities are OBI Pharma, Inc., Oneness Biotech Co., Ltd., TaiMed Biologics Inc., Medigen Vaccine Biologics Corporation, TaiGen Biopharmaceuticals Holdings Limited, GenMont Biotech Incorporation, Abnova (Taiwan) Corporation and Microbio Co., Ltd..
The bottom 10 Vaccines companies in Taiwan by Net Cash Used Provided By Financing Activities are Microbio Co., Ltd., Abnova (Taiwan) Corporation, GenMont Biotech Incorporation, TaiGen Biopharmaceuticals Holdings Limited, Medigen Vaccine Biologics Corporation, TaiMed Biologics Inc., Oneness Biotech Co., Ltd. and OBI Pharma, Inc..